Processa Pharmaceuticals PCSA
NASDAQ PCSA
$1.77 +0.01 (+0.40%)
As of: Oct 22, 2026 · 12:43 PM EDT

Processa Pharmaceuticals (PCSA) Short-term Investments (2018)

Updated

Processa Pharmaceuticals (PCSA) recorded Short-term Investments of $496,201 in Q2 2018.

Analysis

Processa Pharmaceuticals (PCSA) Short-term Investments (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,169.59 Bn 1,138.18 Bn 19.71 Bn
2 Johnson & Johnson 643.18 Bn 561.71 Bn 17.26 Bn
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn
4 Merck 361.55 Bn 315.92 Bn 12.21 Bn
5 Novartis Ag 302.33 Bn 266.32 Bn 11.24 Bn
6 Astrazeneca 267.31 Bn 241.00 Bn 12.86 Bn
7 Amgen 241.52 Bn 196.92 Bn 7.24 Bn
8 Gilead Sciences 193.17 Bn 167.37 Bn 6.22 Bn
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn
10 Processa Pharmaceuticals 4.86 Mn -8.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 496,201.00
API Access

Processa Pharmaceuticals Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=PCSA&period=max&api_key=YOUR_API_KEY